Diabetes, Vol 38, Issue 10 1326-1328, Copyright © 1989 by American Diabetes Association

ARTICLES

High-glucose stimulation of 64,000-Mr islet cell autoantigen expression

O Kampe, A Andersson, E Bjork, A Hallberg and FA Karlsson
Department of Internal Medicine, University Hospital, Uppsala, Sweden.

This study examined the effect of various extracellular glucose concentrations on the expression of a previously described 64,000-Mr islet cell autoantigen associated with insulin-dependent diabetes mellitus. The protein was precipitated from patient serums incubated with Triton X-100 lysates of [35S]methionine-labeled rat pancreatic islets that had been cultured in 5, 11, or 28 mM glucose for 6 h or 3 days. In both types of experiment, 28 mM glucose was the most efficient stimulator of 64,000-Mr autoantigen production. In contrast, the class I antigens of the major histocompatibility complex, precipitated by a rabbit polyclonal antiserum, were not influenced by differences in glucose concentrations. Our data indicate that expression of islet cell antigens may be increased during the course of hyperglycemia and suggest that the functional activity of islet cells influences their antigenicity.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L Zhao, Z Li, M Kullin, L A H Borg, and F A Karlsson Alterations in net glucose uptake and in the pancreatic B-cell GLUT2 transporter induced by diazoxide and by secretory stimuli J. Endocrinol., May 1, 2005; 185(2): 291 - 299. [Abstract] [Full Text] [PDF]

				E. Ortqvist, E. Bjork, M. Wallensteen, J. Ludvigsson, J. Aman, C. Johansson, G. Forsander, F. Lindgren, L. Berglund, M. Bengtsson, et al. Temporary Preservation of {beta}-Cell Function by Diazoxide Treatment in Childhood Type 1 Diabetes Diabetes Care, September 1, 2004; 27(9): 2191 - 2197. [Abstract] [Full Text] [PDF]

				K. Skak, C. F. Gotfredsen, D. Lundsgaard, J. B. Hansen, J. Sturis, and H. Markholst Improved {beta}-Cell Survival and Reduced Insulitis in a Type 1 Diabetic Rat Model After Treatment With a {beta}-Cell-Selective KATP Channel Opener Diabetes, April 1, 2004; 53(4): 1089 - 1095. [Abstract] [Full Text] [PDF]

				D. Pavlovic, M. Van De Winkel, B. Van der Auwera, M.-C. Chen, F. Schuit, L. Bouwens, and D. Pipeleers Effect of Interferon-{gamma} and Glucose on Major Histocompatibility Complex Class I and Class II Expression by Pancreatic {beta}- and Non-{beta}-Cells J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2329 - 2336. [Abstract] [Full Text] [PDF]

				E. S. Husebye, G. Gebre-Medhin, T. Tuomi, J. Perheentupa, M. Landin-Olsson, J. Gustafsson, F. Rorsman, and O. Kampe Autoantibodies against Aromatic L-Amino Acid Decarboxylase in Autoimmune Polyendocrine Syndrome Type I J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 147 - 150. [Abstract] [Full Text] [PDF]

				L Juntti-Berggren, O Larsson, P Rorsman, C Ammala, K Bokvist, K Wahlander, P Nicotera, J Dypbukt, S Orrenius, A Hallberg, et al. Increased activity of L-type Ca2+ channels exposed to serum from patients with type I diabetes Science, July 2, 1993; 261(5117): 86 - 90. [Abstract] [PDF]

				H. Hedstrand, O. Ekwall, M. J. Olsson, E. Landgren, E. H. Kemp, A. P. Weetman, J. Perheentupa, E. Husebye, J. Gustafsson, C. Betterle, et al. The Transcription Factors SOX9 and SOX10 Are Vitiligo Autoantigens in Autoimmune Polyendocrine Syndrome Type I J. Biol. Chem., September 14, 2001; 276(38): 35390 - 35395. [Abstract] [Full Text] [PDF]